• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/19

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

19 Cards in this Set

  • Front
  • Back

Positive iotopic drug

D igoxin


Levosimendan


Omecative mecarbil


Istaroxime



Bipyridines



Beta-agonist

levosimendan

- sensitizes the tropanin system to ca+2


- inhibit phosphodiesterase


- cause some vasodilatation in addition to it’s intropic effect

Beta -agonist

*Dobutamine has been most widely used in HF


-given IV


-produce an increase in cardiac output together with a decrease in ventricular filling pressure


*Dopamine :


- used in acute HF


-and if there is a need to raise blood pressure

Digoxin

- cardiac glycoside


- 65-80% absorbed after oral administration


- Widely distributed to tissue , including the CNS


- Not extensively metabolized in humans


- 2/3 is excreted uncharged by the kidneys


- it’s renal clearance is proportional to creatinine clearance


- half-life is 36-40 h in patient , with normal renal function


- need to adjust digoxin dosage in patient with renal impairment


- positive inotropic drug


- Work by inhibiting the Na+/K+ ATPase



- increase in cardiac contractility

Istaroxime

- Investigational steroid derivative


- Increase contractility by inhibiting Na+/K+ ATPase



-also allows calcium to be stored in the SR so less arrhythmia toxicity than digoxin

Bipyridines (Inamrinone ,Milirinone)

- inhibit phosphodiesterase isozyme 3 (pde-3)


- active orally and parent rally but available only in parental forms


- half-lives 3-6 h


- 10-40% excreted in the urine


- increase in cAMP


- in heart >> increase contractility


- in vessels >> cause vasodilatation


- used only for acute HF or sever exacerbation of chronic HF


- toxicity of inamrinone >> nausea , vomiting , arrhythmias , thrombocytopenia and liver enzyme change



- milirinone appears less likely to bone marrow and liver toxicity than inamrinone but it dose not cause arrhythmias

Natriuretic peptides analogs

Nesiritide


Vlaritide


Caperitide


Bosentan and tezosentan

Diuretics

- furosemide is mostly used in HF


- No direct effect on cardiac contractility


- Reduce venous pressure and ventricular preload


- reduction of salt and retention and edema and it’s symptoms


- reduction of cardiac size >> lead to improve pump efficiency



- spironolactone and eplerenone >> the aldesterone antagonist diuretics >> decreasing and mortality

Used in HF Drug without positive iotropic effect

Diuretics


ACE inhibitors


ARBs and aliskiren


Vasodilators


Beta blockers

ACE inhibitors (captopril)

- reduce preload and after load


- reduce salt and water retention


- reduce the long-term remolding of the heart and vessels


- reduce mortality and morbidity in patient with HF

Omecativ mercarbil

- Alter the rate of transition of myosin from low-- action-binding state to strongly action-bound force generating state


- still in development

Beta blockers

- Used for chronic HF


- only bisoprolol , carvedilol , metoprolol and nebivolol are used


- reduce mortality and morbidity



- decrease remodeling of heart

Vasodilators

- Effective also in acute HF


- reduction in preload (through venodilation)


- reduction in after load (through arteriolar dilation )


- hydrolazine / isosorbide dinitrate >> reduce damaging remodeling of the heart

Nesiritide

- Synthetic from of the brain natriuretic peptide (BNP)


- Increase cGMP in smooth muscle and reduce venous and arteriolar tone


- it also causes diuresis


- Short half-life > 18 minutes


-The most common adverse effect >> excessive hypotension

losartan

ARB-AT1 antagonist :



can be used when ACE inhibitors cause cough or angioedema

Alisikirin

-rennin inhibitors



-similar to ACE inhibitors

Vlaritide

-synthetic from of urodilation



- similar to BNP , under investigation

Caperitide :

- synthetic from of atrial natriuertic peptide (ANP)



- similar to BNP , under investigation

Bosentan and tezosentan

- Competitive inhibitors of endothelium



- But they are only approved for use in pulmonary hypertension , not heart failure